1 Frisinghelli A, Mafrici A.Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease:A Review[J].Clin Drug Investig, 2007;27:591-604. 2 Baumbach GL, Heistad DD.Remodeling of cerebral arterioles in chronic hypertension[J].Hypertension, 1989;13:968-972. 3 Owens GK.Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells[J].Am J Physiol, 1989;257; H1755-H1765. 4 Panza JA, Quyyumi AA, Brush JE Jr, et al.Abnormal endothelium dependent vascular relaxation in patients with essential hypertension[J].N Engl J Med, 1990;323:22-27. 5 Schulze-Bauer CA, Regitnig P, Hotzapfer GA.Mechanics of the human femoral adventitia including the high pressure response[J].Biomech, 2002;282:H2427-H2440. 6 Stenmark KR, Gerasimovskaya E, Nemenoff RA, et al.Hypoxic activation of adventitial fibroblasts role in vascular remodeling[J].Chest, 2002;122:S326-S334. 7 Gonz? lezMC, Arribas SM, Molero F, et al.Effect of removal of adventitia on vascular smooth muscle contraction and relaxation[J].Am J Physiol Heart Circ Physiol, 2001;280:H2876-H2881. 8 Ge CJ, Hu SJ, Wu YS, et al.Effects of atorvastatin on vascular remodeling in spontaneously hypertensive rats[J].J Zhejiang Univ Sci, 2003;4:612-615. 9 Straznicky NE, Howes LG, Lam W, et al.Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin Ⅱ in patients with hypercholesterolemia and systemic hypertension[J].Am J Cardiol, 1995;75:582-586. 10 Borghi C, Prandin MG, Costa FV, et al.Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia[J].J Cardiovasc Pharmacol, 2000;35:549-555. 11 王安才, 谢晓竟, 徐浩, 等.阿托伐他汀对自发性高血压大鼠血压和心肌血管紧张素II 1 型和2 型受体表达的响[J].中国动脉硬化杂志, 2005;13:40-44. 12 Dzau VJ.Theodore Cooper Lecture:Tissue angiotensin and pathobiology of vascular disease:a unifying hypothesis[J].Hypertension, 2001;37:1047-1052. |